Cargando…

Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways

Cognitive impairment is highly prevalent in patients with Parkinson’s disease (PD) and causes adverse health outcomes. Novel procognitive therapies are needed to address this unmet need. It is now established that there is an increased risk of dementia in patients with type 2 diabetes mellitus (T2DM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Holly, Tsitsi, Panagiota, Markaki, Ioanna, Aarsland, Dag, Svenningsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373401/ https://www.ncbi.nlm.nih.gov/pubmed/30687888 http://dx.doi.org/10.1007/s40263-018-0601-x

Ejemplares similares

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson’s disease
por: Waldthaler, Josefine, et al.
Publicado: (2019)

Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease
por: Tsitsi, Panagiota, et al.
Publicado: (2021)

Pupil light reflex dynamics in Parkinson’s disease
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Neurocognitive profile of adults with the Norrbottnian type of Gaucher disease
por: Tsitsi, Panagiota, et al.
Publicado: (2021)

Synaptic proteins in CSF relate to Parkinson’s disease stage markers
por: Bereczki, Erika, et al.
Publicado: (2017)

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
por: te Vruchte, Danielle, et al.
Publicado: (2022)

Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
por: Svenningsson, Per, et al.
Publicado: (2018)

Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease
por: Paslawski, Wojciech, et al.
Publicado: (2023)

Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
por: Rektorova, Irena, et al.
Publicado: (2014)

Reduction of spontaneous cortical beta bursts in Parkinson’s disease is linked to symptom severity
por: Vinding, Mikkel C, et al.
Publicado: (2020)

Impaired synaptic function is linked to cognition in Parkinson's disease
por: Selnes, Per, et al.
Publicado: (2017)

A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism
por: Papathoma, Paraskevi-Evita, et al.
Publicado: (2022)

Attenuated beta rebound to proprioceptive afferent feedback in Parkinson’s disease
por: Vinding, Mikkel C., et al.
Publicado: (2019)

Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases
por: Hessen, Erik, et al.
Publicado: (2016)

Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
por: Bougea, Anastasia, et al.
Publicado: (2023)

Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson’s Disease
por: Green, Holly F., et al.
Publicado: (2019)

Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
por: Grambaite, Ramune, et al.
Publicado: (2013)

Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits
por: Lebedev, Alexander V., et al.
Publicado: (2014)

Cognitive Interventions in Parkinson’s Disease: Where We Want to Go within 20 Years
por: Kalbe, Elke, et al.
Publicado: (2018)

White matter integrity and cognition in Parkinson's disease: a cross-sectional study
por: Auning, Eirik, et al.
Publicado: (2014)

Impaired migratory phenotype of CD4(+) T cells in Parkinson’s disease
por: Mamula, Dejan, et al.
Publicado: (2022)

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2021)

Novel targeted therapies for Parkinson’s disease
por: Ntetsika, Theodora, et al.
Publicado: (2021)

Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson’s disease: a cross-sectional study
por: Stav, Ane Løvli, et al.
Publicado: (2016)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
por: Creese, Byron, et al.
Publicado: (2021)

Cognitive Profile of Elderly Patients with Mild Stroke
por: Gramstad, Arne, et al.
Publicado: (2011)

Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine
por: Dave, Sonali, et al.
Publicado: (2019)

Antidepressant-like properties of sarizotan in experimental Parkinsonism
por: Zhang, Xiaoqun, et al.
Publicado: (2011)

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
por: Caspell-Garcia, Chelsea, et al.
Publicado: (2017)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
por: Prasuhn, Jannik, et al.
Publicado: (2021)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Screening for Alzheimer’s Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
por: Kirsebom, Bjørn-Eivind, et al.
Publicado: (2017)

Mediating Effect of Mutuality on Health-Related Quality of Life in Patients with Parkinson's Disease
por: Karlstedt, Michaela, et al.
Publicado: (2018)

Determinants of Dyadic Relationship and Its Psychosocial Impact in Patients with Parkinson's Disease and Their Spouses
por: Karlstedt, Michaela, et al.
Publicado: (2017)

Parkinson's Disease and Cognitive Impairment
por: Yang, Yang, et al.
Publicado: (2016)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
por: Fazio, Patrik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_55mklhinr3ojdo2u4bnkopui19